In support of an anti-tumor function of GPR15 in human CRC, GPR15 expression as well as GPR15+ immune cells were significantly reduced in human colon tumors and lower GPR15 expression correlated with decreased survival of COAD patients. This evidence concerns the gene GPR15 and colorectal carcinoma.